Jurassic Products: FDA Resurrects Withdrawn Drugs To Study Liver Injury
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency soliciting contractor to produce 37 drugs withdrawn because of liver injury; goal is developing better tools for evaluating compounds in the pipeline.